US Food and Drug Administration Expanded Adjuvant Indication of Abemaciclib in High-Risk Early Breast Cancer. Royce M, Mulkey F, Osgood C, Bloomquist E, et al. J Clin Oncol 2023 Apr 27:JCO2300615. doi: 10.1200/JCO.23.00615.

Read + Share

Amedeo Smart

Independent Medical Education

Royce M, Mulkey F, Osgood C, Bloomquist E, et al. US Food and Drug Administration Expanded Adjuvant Indication of Abemaciclib in High-Risk Early Breast Cancer. J Clin Oncol 2023 Apr 27:JCO2300615. doi: 10.1200/JCO.23.00615.
PMID: 37104738